What is TFX's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 5.53B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for TFX?

P/E (TTM) is n/a and 52-week range is $100.18 to $145.00 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s TFX figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for TFX?

The company profile lists revenue (TTM) near $2.64B, net income (TTM) near $-104.61B, EPS (TTM) near $-23.29 when available from the market-data feed. Figures are informational and may lag live markets.

Does TFX show a dividend on Chartloom?

The overview lists dividend per share (TTM) near $1.38, yield near 1.12%, ex-dividend date Aug 14, 2026 when those figures are present. Dividend history is compiled from vendor data, not a distribution notice.

Where is Teleflex Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Wayne, Pennsylvania, US, 44.3M shares outstanding, ISIN US8793691069 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Free AI scores & summaries library

Teleflex Inc

$TFX

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$130.43

+1.72%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Teleflex, Inc. engages in the provision of medical technology products. The company is headquartered in Wayne, Pennsylvania and currently employs 15,500 full-time employees. The firm offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.

Employees

15,500

Website

www.teleflex.com/usa/en/#

IPO

1980-03-17

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)